THE BALANCEhttps://thebalance.clinic/resources/addiction/drugs/kratom-addiction/

Swiss roots. International expertise. Personal care, delivered with privacy and discretion.

THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Privacy and discretion from the first conversation.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Swiss entrepreneur · Founder & CEO

Clinical resource

Kratom: Dependence, Health Risks and Treatment Support

Understand kratom product differences, dependence, withdrawal, serious warning signs and how to seek appropriate medical support.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Kratom products vary, and concentrated 7-OH products have additional safety concerns.
  • There is no approved medical use or universal safe dose established by the FDA.
  • Dependence and adverse effects deserve assessment; breaks and hydration do not guarantee prevention.

Kratom is a plant, Mitragyna speciosa, whose leaves contain psychoactive alkaloids. Products are sold as powders, capsules, extracts and other preparations. Their composition can vary substantially. Kratom can cause dependence and other health problems, and a “natural” label does not establish safety or treatment effectiveness.

What is known about its effects?

Mitragynine and related alkaloids interact with opioid receptors and other biological targets. People report using kratom for pain, mood, energy or opioid withdrawal, but those reported reasons are not proof of clinical benefit. The FDA has not approved kratom or its alkaloids to treat any medical condition.

Botanical kratom and products with added or enhanced 7-hydroxymitragynine, often called 7-OH, should not be treated as interchangeable. The FDA has issued specific warnings about concentrated 7-OH products. A general statement that all kratom is weaker or safer than conventional opioids does not account for product variability or individual risk.

Dependence and problematic use

Repeated exposure can lead to physical dependence, meaning symptoms may occur when use is reduced or stopped. A use disorder involves impaired control and continued use despite significant harm. These concepts overlap but are not identical, and there is no fixed sequence or universal time to addiction.

  • Taking more or using more frequently than intended.
  • Difficulty cutting down despite wanting to change.
  • Spending substantial time obtaining or using products.
  • Continuing despite health problems or effects on responsibilities and relationships.
  • Withdrawal symptoms when use is reduced.

These are reasons for assessment, not a self-diagnostic checklist. Tell the clinician which products you use, how often, approximately how much and what other medicines or substances are involved. A photograph or packaging may help identify the product.

Health risks and urgent symptoms

Reported adverse effects include nausea, constipation, dizziness and drowsiness. Serious concerns include seizures, liver injury and substance use disorder. Reports involving several substances can be difficult to attribute to kratom alone, but that uncertainty does not make combinations safe. Contamination or inaccurate labeling adds further risk.

Call emergency services for slow or abnormal breathing, a seizure, collapse or difficulty waking someone. Seek urgent medical assessment for jaundice, severe abdominal symptoms, confusion or a suspected overdose. Tell responders about kratom and any other substances taken.

Avoid combining kratom with alcohol, opioids, benzodiazepines or other sedatives. Do not drive when impaired. Do not rely on a seller’s recommended quantity as a medically established safe dose.

Withdrawal and treatment

Withdrawal may involve anxiety, irritability, sleep problems, muscle aches, gastrointestinal symptoms and cravings. Severity and duration vary. A clinician can assess symptoms, product exposure, other substance dependence and co-occurring conditions and agree an appropriate plan. There is no single proven self-directed taper suitable for every product and person.

If you are using kratom to manage pain, anxiety or opioid withdrawal, discuss evidence-based alternatives with a qualified professional. For opioid use disorder, medicines such as methadone or buprenorphine can be part of established care. Do not replace prescribed treatment with kratom without advice.

Support can include medical follow-up, psychological care and practical help. More intensive care may be needed for serious complications or additional substance withdrawal. Treatment should also address the reason someone began using kratom.

Questions

Frequently Asked Questions

Do breaks prevent addiction?

There is no validated schedule of breaks that guarantees prevention or “resets” tolerance. Hydration or using kratom for a particular purpose also does not remove the risk.

Is there a safe recommended dose?

A universal safe dose cannot be established from a label or online advice. Preparations differ, including concentrated extracts and enhanced 7-OH products.

Does being sold legally mean it is an approved medicine?

No. Product availability and medical approval are different. Laws vary by jurisdiction and can change; the FDA has not approved kratom products for medical treatment in the United States.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

02FDA: products containing concentrated or enhanced 7-OHView source
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care